Clinical Trial Update: Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating short-term effects of ivacaftor in cystic fibrosis patients without the G551D mutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (ivacaftor)

Snippet

Sponsor: University of California, San Francisco | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2020-09-29